Chun-lin Liu

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Ergostatrien-3β-ol suppresses breast cancer anoikis resistance and metastasis by targeting the miR-93-5p/leupaxin axis.

Ergostatrien-3β-ol suppresses breast cancer anoikis resistance and metastasis by targeting the miR-93-5p/leupaxin axis.

Journal: European journal of pharmacology

Published: February 27, 2026

Targeting Netrin-1 Mediates the Suppression of Osteolytic Bone Metastasis in Breast Cancer by Ugonin L.

Targeting Netrin-1 Mediates the Suppression of Osteolytic Bone Metastasis in Breast Cancer by Ugonin L.

Journal: International journal of biological sciences

Published: November 25, 2025

C-X-C motif chemokine ligand 13 suppresses osteoclast differentiation via interference with RANKL-RANK interaction.

C-X-C motif chemokine ligand 13 suppresses osteoclast differentiation via interference with RANKL-RANK interaction.

Journal: Frontiers in immunology

Published: October 21, 2025

Visfatin facilitates esophageal cancer migration by suppressing miR‑3613‑5p expression and promoting VEZF1/VCAN production.

Visfatin facilitates esophageal cancer migration by suppressing miR‑3613‑5p expression and promoting VEZF1/VCAN production.

Journal: Oncology reports

Published: April 28, 2025

Bone sialoprotein facilitates anoikis resistance in lung cancer by inhibiting miR-150-5p expression.

Bone sialoprotein facilitates anoikis resistance in lung cancer by inhibiting miR-150-5p expression.

Journal: Journal of cellular and molecular medicine

Published: April 15, 2024

Cigarette smoke promotes IL-6-dependent lung cancer migration and osteolytic bone metastasis.

Cigarette smoke promotes IL-6-dependent lung cancer migration and osteolytic bone metastasis.

Journal: International journal of biological sciences

Published: January 16, 2024

Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathways.

Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathways.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 11, 2023

Visfatin upregulates VEGF-C expression and lymphangiogenesis in esophageal cancer by activating MEK1/2-ERK and NF-κB signaling.

Visfatin upregulates VEGF-C expression and lymphangiogenesis in esophageal cancer by activating MEK1/2-ERK and NF-κB signaling.

Journal: Aging

Published: March 23, 2023

Bone sialoprotein promotes lung cancer osteolytic bone metastasis via MMP14-dependent mechanisms.

Bone sialoprotein promotes lung cancer osteolytic bone metastasis via MMP14-dependent mechanisms.

Journal: Biochemical pharmacology

Published: February 02, 2023

ANGPTL2 promotes VEGF-A synthesis in human lung cancer and facilitates lymphangiogenesis.

ANGPTL2 promotes VEGF-A synthesis in human lung cancer and facilitates lymphangiogenesis.

Journal: Aging

Published: December 20, 2022

Apelin Promotes Prostate Cancer Metastasis by Downregulating TIMP2 via Increases in miR-106a-5p Expression.

Apelin Promotes Prostate Cancer Metastasis by Downregulating TIMP2 via Increases in miR-106a-5p Expression.

Journal: Cells

Published: September 04, 2022

Melatonin suppresses the metastatic potential of osteoblastic prostate cancers by inhibiting integrin α2 β1 expression.

Melatonin suppresses the metastatic potential of osteoblastic prostate cancers by inhibiting integrin α2 β1 expression.

Journal: Journal of pineal research

Published: October 21, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026